The t10w of new information on gene expression re lated to apoptosis has been relentless in the last several years. This has also been the case with respect to gene expression after cerebral ischemia. Many of genes asso ciated with an apoptotic mode of cell death have now been studied in the context of experimental cerebral isch emia from the immediate early genes through modulat ing genes such as bcl-2 to genes in the final execution phase such as interleukin-Ij3 converting enzyme (lCE) related proteases. It was impossible to adequately cite all primary reports on these subjects. However, many excel lent reviews have appeared in the last year, which to gether, cover all these areas of interest. In this review, we have elected to<cite only reports published since January 1996 and use an extensive collection of reviews (indi cated in italics) to guide the reader to the earlier litera ture. Our intent is to provide the reader with a timely and useful analysis of the current state of the art. It is hoped that this approach does not cause offense with our col leagues whose contributions before 1996 laid the foun dation for much of this work.
THE YEAR IN REVIEW: 1996
A general review very useful to those just starting to seek an understanding of apoptosis, which also includes details of protease cascades and therapeutic possibilities, was written by Duke et al. (1996) . In summarizing signal transduction involved with apoptosis, McConkey and Or renius (1996) highlighted the difficulty with generaliza tions, and emphasized the importance of the context in which signals are processed by cells by the statement "signals that promote apoptosis in one model can sup press cell death in another." Cells are overproduced dur ing development to form tissues and then culled by pro grammed cell death to adjust numbers and sculpt the final form, a process eloquently derived by Jacobson et al. (1997) .
The molecular regulation of apoptosis was reviewed from different perspectives by Desbarats et a!. (1996) , Hale et a!. (1996) , Nagata (1997) and Vaux and Strasser (1996) with emphasis on the conserved phylogenetic na ture of the cell death machinery, and its interlocking with the control of cell proliferation in conjunction with in t1uence of extracellular factors such as cytokines. The degradative enzymes such as the ICE-like proteases and endonucleases were specifically covered by Montague and Cidlowski (1996) , MundIe et a!. (1996) , Nicholson (1996) , Schwartz and Milligan (1996) , and Ashkenhas and Werb (1996) . A nomenclature for the human ho mologs of the ICE/Ced-3 proteases, now called caspases (cysteine proteases cleaving after an asp residue) has been defined based on phylogenetic relationships (AI nemri et a!. , 1996) . The Bcl-2 family of proteins, con taining apoptosis inhibitors and inducers, was analyzed by Yang and Korsymeyer (1996) and Kraemer (1997) while Bredesen (l996a,b) specifically addressed the Bcl-2 family in neurons.
Several lines of evidence point to a central role for mitochondria in effecting apoptotic cell death. The dis ruption of the mitochondrial transmembrane potential and opening of the permeability transition pore early in apoptosis are linked with release of some mitochondrial substance that appears capable of inducing apoptotic characteristics in cell free systems (Kraemer et a!. , 1997) . A clinical assessment of the applicability of this basic knowledge, particularly of the signalling of cell death from the TNF family of receptors, left the reader with the understanding of the work still to be done before practical benefit will be possible (Rudin and Thompson 1997), and concluded with' 'T he era of widespread clini cal implementation of apoptotic modulation in the treat ment of disease has not yet arrived."
How this general understanding of apoptotic cell death applies to neurons in particular was covered by Bredesen (1996 a, b) , Linnik (1996) , Mattson and Furukawa (1996) , Waters (1996) . These texts cover the definitions of apoptosis, the elegant genetic 1. P. MacMANUS AND M. D. LINNIK work performed on cell death in the nematode C. el egans, genes that promote cell death (eg,jun, myc, p53) , genes that oppose cell death (eg bcl-2, lAP), neuronal death during development, and an evaluation of potential pharmacological and therapeutic intervention strategies. The specific involvement of apoptosis after cerebral ischemia was reviewed in several publications (Charri aut-Merlangue, et aI. , 1996a; Chopp and Li, 1996; Edwards and Mehmet, 1996; Ferrer 1996; Mehmet and Edward$, 1996) that cover some of the same ground as the reviews above but also delve into the thorny issue of neuronal necrosis. The central role for. excitotoxicity inducing cellular mortality via changes in calcium tran sients was also considered (Bennett and Huzlin, 1996; and links were made with changes in the mitochondrial permeability transition pore (Kristian and Siesjo 1996; Siesjo and Siesjo 1996) . Immediate early gene expression such asfos and jun in brain (Akins et aI. , 1996; Herzog and Morgan, 1996) and other stress genes such as heat shock proteins (Massa et aI. , 1996) have al so become a major area of investigation.
Another rapidly evolving area concerning gene ex pression induced by cerebral ischemia relates to neuro inflammation, cytokines and adhesion molecules (Arvin et aI. , 1996; Matuso et aI. , 1996) , and in cludes interleukin-l (Betz et aI., 1996) . Finally, there is no doubt as to the importance of oxidative damage caused by hydroxyl, superoxide, or nitric oxide radicals in the evolution of the ischemic infarct and general neu rotoxicity (Chan, 1996; Dawson and Dawson 1996; Hosler and Brown 1996; ladecola, 1997; Szabo 1996) , and it is now likely that future therapeutic treatments for stroke will have an antioxidant component. It is here that we come full circle because of the importance of oxida tive mechanisms in controlIing apoptosis (Brede sen 1996b; Hale et aI., 1996; McConkey and Orrenius, 1996; Mattson and Furukawa 1996) . An overall scheme defin ing many of the intracellular factors that influence the survival of a cell after a stroke are indicated in Fig. 1 .
THE BcI-2 GENE FAMILY: APOPTOSIS

INHIBITORS AND INDUCERS
The Bcl-2 family of proteins are homologous to the ced-9 gene product in C. elegans that has the remarkable property of inhibiting developmental cell death, particu larly in the nervous system. There are now several mem-bers of the Bcl-2 family ( Table 1 ) that are structurally, but not functionally, homologous. In an intriguing tum of evolution, the original ced-9 gene has evolved into a family of genes with specific members that inhibit ap optosis and others that promote apoptosis.
The analysis of the bcl-2 gene family in ischemic stroke is still in its infancy, but the initial results suggest an important role in determining neuronal survival. In vitro studies showed that Bcl-2 protected cells against a wide variety of ,insults, including excitotoxicity, elevated calcium, lipid peroxidation, and free-radical damage.
The important role of these factors in ischemia suggested that increased Bcl-2 expression might be protective in animal models of stroke. A neuroprotective effect of Bcl-2 has been shown in transgenic animals that overex press Bcl-2, or when viral vectors are used to overex press Bcl-2 in focal, or global ischemia Chopp and Li, 1996; Linnik 1996; Lawrence et aI., 1996) .
Several studies have analyzed the expression of the proapoptotic and antiapoptotic members of the bcl-2 gene family after focal and global cerebral ischemia. To date, these studies have specifically concentrated on the protective proteins Bcl-2 and Bcl-xL and the death en hancing Bax protein as these proteins have been shown to be important determinants of neuronal apoptosis in the developing brain (Deckwerth et aI., 1996; Shindler et aI., 1997) . In gener�l, the results from stroke studies have been consistent with the known functions of these pro teins. Specifically, the proapoptotic Bax protein is up regulated in neurons that are destined to die in both glob al ischemia (Chen et aI., 1996; Hara et aI., 1996) and focal ischemia (Gillardon et aI., 1996b) while its expres sion remains constant in neurons that survive the isch emic insult. The expression of Bcl-2 and Bcl-xL after ischemia is also consistent with their known function as inhibitors of apoptosis. Both Bcl-2 and Bcl-xL are per sistently expressed in neurons that survive in focal isch emia (Gillardon et aI., 1996b; Asahi et aI., 1997) and global ischemia (Honkaniemi et aI., 1996a; Chen et aI., 1996 and . The differential expression of these family members is most remarkable in the global isch emia models where the cell death is localized to the vulnerable CA 1 hippocampal neurons. Thus, Bax over- Studies on the transcriptional regulation of the bcl-2 genes has led to interesting descriptions of known apop totic factors influencing transcription in this gene family.
For example, the p53 tumor suppressor protein can in crease the expression of bax mRNA, possibly as an ad junct mechanism for inducing cell deletion. The potential relevance of this mechanism to excitotoxicity was shown by Hughes et al. (1996) who showed that a quinolinic excitotic lesion in rats induced p53 expression that led to a increase in bax mRNA.
The search for the mechanism(s) underlying the anti apoptotic effects of Bcl-2 have been underway since the discovery of the Ced-9 gene in C. elegans. One early observation was the demonstration of single transmem brane region driving the subcellular localization of Bcl-2 primarily to mitochondrial and nuclear membranes. This suggested that the protective effect of Bcl-2 was related to the preservation of mitochondrial function and/or nuclear integrity. However, molecular studies deleting the transmembrane region proved that the membrane lo calization was not absolutely necessary for the antiapop totic activity. In addition, Bcl-2 was able to block apop tosis in cells that did not contain mitochondria, again suggesting that mitochondrial membrane localization was not critical for function (Yang and Korsmeyer, 1996; Zhu et aI., 1996) . The search for a mechanism related to Bcl-2 was further frustrated by the inability to demon strate any effect of Bcl-2 on normal organelle function, including mitochondrial respiration or nuclear transport.
The data suggested that Bcl-2 was an innocuous protein with no readily discernible function except the potent and promiscuous prevention of apoptotic and even ne crotic cell death in many cell types and cell death models (Bredesen, 1996a) .
Perhaps the largest single gap in the literature con cerning Ced-9 and Bcl-2 has been the lack of a firm connection between Bcl-2 and the other critical compo nent of the apoptotic cascade, the Ced-3/caspase family of proteases. In C. elegans, the caspase Ced-3 is abso-
How does BcI-2 inhibit apoptosis?
Bcl-2 inhibits both apoptosis and necrosis. However, Bcl-2 ex pression has little effect on metabolic function in normal cells.
Several lines of investigation are now suggesting mechanisms by which Bel-2 might prevent cell death and many of these mechanisms may be applicable to ischemic cell death.
• Regulation by dimerization. The cumulative response to the Bel-2 family members in a cell is in part regulated by dimerization domains within this family. For example, the ability of Bt:l-2 to inhibit apoptosis is blocked by the forma tion of a heterodimer with Bax (Yang and Korsmeyer, 1996) .
The binding of these proteins is dependent 0'l1 three conserved regions, BH1, BH2, and BH3. Deletion studies indicate that the BH1 and BH2 domains are responsible for the formation of Bel-2 homodimers whereas the BH3 domain has an im portant functional role in the death promoting family mem bers, ineluding Bax, Bak and Bip (Zha et al., 1996; Sattler et al., 1997) .
At present, the majority of dimerization data can best be fit to two potential models (Gajewski and Thompson, 1996) phorylation attenuates the protective effect of Bel-2 while deleting the target serine residue enhances the activity of Bel-2 (Gajewski and . Phosphorylation of proapoptotic Bad alters its normal affinity for Bel-xL and leads to the sequestration of Bad in the cytoplasm where it cannot interact with Bel-X L (Zha et aI., 1996) . Thus, different phosphorylation states of the Bel-2 family members alter the acti vities of these proteins, possibly by altering their affinity for Bel-2 family members and other proteins in the cell.
• Local inhibition of free radical production. Early mechanistic studies suggested that Bel-2 inhibited the accu mulation of lipid peroxides (Yang and Korsmeyer, 1996) .
While this mechanism was hotly debated, the anti-oxidant effects were not observed in all models and subsequently this hypothesis has attracted less interest. However, the extensive oxidative injury in ischemic neuronal death suggests that an antioxidant mechanism for Bel-2 would be beneficial and might exhibit a greater contribution in those cases where oxi dative damage is a significant component of the cell death triggering event.
• Formation of an ionic conductance channel in mem branes. The Bel-XL protein contains two central hydrophobic a helices surrounded by five amphipathic helices (Muchmore et al., 1996) , a structure similar to the pore-forming domain of certain bacterial toxins. Minn et al. (1997) demonstrated that Bel-XL can insert into membranes and form an ionic conduc tance channel that is cation selective at physiological pH. The implications for ischemia inelude the possibility that Bel-XL cessing and subunit rearrangement to yield active en zyme. Specifically, the proenzyme is cleaved at Asp-X junctions to yield a large subunit (p20) and a small sub unit (piO). The crystal structure of caspase-l suggests that the large and small subunits heterodimerize and two independent pI O/p20 heterodimers associate to form a (piO/p20h tetramer with two active sites at opposite ends (1996) classified the human homologs of the ICE! Ced-3 family of proteases as capsases. Specific caspase members are identified along with their previous designations.
BOX 1. (cont'd)
could regulate the sequestration of intracellular calcium that is an important component of the excitotoxic cell death mechanism.
• Regulation of permeability transition in mitochondria. The asymmetric distribution of ions across the inner mito chondrial membrane maintains the transmembrane potential that drives A TP production. While apoptotic mitochondria show an early reduction in the transmembrane potential, they can also underg0 complete collapse when atypical complexes develop between the inner and outer mitochondrial mem branes. This permeability transition leads to a cessation of ATP synthesis, release of sequestered calcium, and a local increase in production of reactive oxygen species in the mi tochondria (Kroemer et al., 1997) . Studies examining the overexpression of Bc1-2 indicate that Bc1-2 does not prevent the early gradual reduction in the transmembrane potential.
However, when Bc1-2 is expressed in the outer mitochondrial membrane it inhibits the permeability transition to several apoptosis inducers (Zamzami et aI., 1996; Marchetti et aI., 1996) In addition to preventing permeability transition, Bc1-2 also enhances the calcium uptake capacity of the mitochondria and provides mitochondria with a greater resistance to Ca++ in duced respiratory injury (Murphy et a!., 1996) . All of these factors suggest that Bc1-2 stabilizes mitochondria in apoptosis and increases the capacity of a cell to sequester the increased calcium seen in fschemic injury.
• Prevention of cytochrome c release from mitochondria. of the complex (Schwartz and Milligan, 1996; Nichol son, 1996) . Thus, the caspases are well situated to regu late apoptotis since they are normally expressed in an inactive configuration and activation only occurs when an apoptotic signal is received.
The caspase family contains several members with unique tissue distribution, substrate specificity, and acti vation criteria. Particular attention has been directed to the caspase-3 (CPP32) homolog because of its profile of preferred substrates that are clearly different than that of caspase-l (rCE) (Schwartz and Milligan, 1996; Nichol son, 1996) . For example, caspase-l is very potent at con verting pro-IL-ll3 to IL-II3, whereas caspase-3 has rela tively little affinity for this substrate. In contrast, caspase-3 has a much higher affinity relative to caspase-l for the DNA repair enzyme, poly (ADP ribose) polymerase (see Box 2). In addition, caspase-3 has the greatest degree of homology to the Ced-3 cell death gene in C. elegans.
Compelling data linking caspase-3 to neuronal apop tosis comes from caspase-3 genetic knockout animals (Kuida et aI., 1996) . Although deleting the caspase-3 gene resulted in 100% lethality by week 3 of fetal de velopment, these animals showed significant neuronal Recent data indicates that cytochrome c released from mito chondria can activate CPP32-like caspases and drive apop totic cell death (X. Kluck et al., 1997) . Bc1-2 expression prevents the release of cytochrome c from the mitochondria, preventing the activation of caspases and pre venting apoptosis (X. Liu et aI., 1996; Yang et aI., 1997) .
These observations provide a direct molecular link between the function of Bc1-2 and the subsequent activation of caspases.
There are also observations suggesting that Bc1-2 prevent the release of an apoptogenic protease from the mitochondria, perhaps as a result of the permeability transition (Martins and Earnshaw, 1997; Susin et aI., 1996) . However, the structure of this protein has yet to be identified.
• Interactions with Ced-4 and Ced-3. The nematode C. elegans has two important genes for cell killing, Ced-3 and Ced-4. Ced-3 is the parent gene of the caspase family. How ever, intensive investigation has yet to reveal a mammalian homolog of Ced-4. Thus, several researchers have begun in vestigating the role of the nematode Ced-4 in mammalian apoptosis models. Ced-4 retained its cell killing activity in mammalian cells. In addition, Ced-4 was shown to interact with Bc1-2 which inhibited the cell killing effect of Ced-4 (Chinnaiyan et aI., 1997; Wu et aI., 1997) . Furthermore, Ced-4 can also interact with members of the caspase family and alter their function. Thus, these studies provide a direct biochemical link between the Bc1-2 family of proteins and the caspases.
hyperplasia. These supernumerary cells were postmi totic, terminally differentiated, and were defined as neu rons by histological and immunohistochemical methods.
Interestingly, the caspase-3 knockout phenotype was largely confined to the nervous system as no abnormali ties were identified in several other organ systems.
Caspase activation in ischemia
Currently, the most direct method for implicating the caspases in cell death is to use selective caspase inhibi tors in a cell death model. Reasonable degrees of selec tivity can be obtained with tetrapeptide inhibitors, while shorter peptides display a more promiscuous enzyme in hibition profile. The commercially available inhibitors typically use a carboxyl terminal aldehyde or ketone functionality as the activated warhead. To generate specificity, the active functionality is coupled to an amino acid recognition sequence that is based on known substrate cleavage sites for the specific caspase (Nichol son, 1996) . Thus, the YV AD aldehyde shows> 10,000fold specificity for caspase-l (Ki � 1 nmol/L) over caspase-3 (Ki = 12 /LmollL). In contrast, the DEVD aldehyde is a subnanomolar inhibitor of caspase-3, al though it also shows reasonable activity against caspase-820 1. The amino tenninus in these inhibitors is critical for distinguishing between caspase family members and truncation to a tripeptide results in the loss of the ability to distinguish between family members.
Two recent studies have reported that intracerebroven tricular administration of caspase inhibitors can protect the brain from ischemia. Loddick et al. (l996a) showed that intracerebroventricular administration of the irre versible caspase inhibitor z-V AD-DeB was protective in a focal cerebral ischemia model. Hara et al. (1997) used tetrapeptide inhibitors to show neuroprotection with a caspase-l specific inhibitor (YVAD-chloromethyl ketone) and a caspase-3 inhibitor (DEVD-fluoromethyl ketone). The pharmacology of this protection is not com pletely resolved because the caspase-3 inhibitor (which also inhibits caspase-l to a lesser extent) seemed to be less efficacious than the caspase-l specific inhibitor used in this study (Hara et aI., 1997) . In the case of the caspase-l inhibitor, a component of the protection may be caused by inhibition of IL-ll3 production, because the caspase-l inhibitor, but not the caspase-3 inhibitor, at tentuated IL-ll3 levels in the brain at 30 minutes after ischemia (see below).
Caspase-lIIL-l(l in ischemia
The data linking caspase activation to ischemia induced apoptosis is primarily based on the pharmaco- Both IL-ll3 mRNA and caspase-l expression are in creased in the postischemic brain. While the increase in IL-ll3 mRNA occurs rapidly and can be attributed to endogenous cells in the brain, the increase in caspase-l occurs in a delayed manner and is confined to activated microglia (Bhat et aI., 1996) . These changes in caspase-l and IL-l!3 seem to have detrimental consequences in the ischemic brain because several studies have shown that a therapeutic benefit can be derived by blocking the action of IL-113 after an ischemic insult. Direct inhibition of IL-l !3 coupling to the IL-ll3 receptor clearly causes a reduction in infarct volume and cerebral edema in isch emia models (Betz et aI., 1996) and the original obser vations have been validated in recent studies (Relton et aI., 1996; Loddick and Rothwell, 1996b) . Friedlander et al. (1996a) have described a transgenic mouse line that expresses an inhibitor of caspase-l in neurons. These mice showed decreased infarcts and improved neurologi cal outcome relative to their wild-type littermates. As a cautionary note, it should be remembered that the pro duction of IL-l(3 during caspase-l dependent apoptosis is not obligatory, although it can be a contributing factor (Friedlander et a!., 1996b) . It remains difficult to disso ciate potentially apoptotic caspase-l activation from IL-1(3 production in the ischemia models, and it is possible that some of th� protective effects observed with caspase inhibitors involve anti-inflammatory effects rather than direct inhibition of apoptosis.
Caspase transcription in cerebral ischemia
Although it is important to recognize that transcliption of new caspases is not a requirement for apoptosis be cause these enzymes are constitutively expressed as pro enzymes and are activated by proteolysis, recent studies have examined the transcription of selected caspases af ter global and focal cerebral ischemia. After permanent focal ischemia, Nedd-2 and caspase-3 mRNA were in duced between 8 and 16 hours after the insult, while the expression of caspase-1 remained constant (Asahi et aI., 1997) . These delays in expression are reasonably late in the ischemic cascade and their pathophysiological sig nificance remains to be determined.
Caspase-1 mRNA is induced in the hippocampus after global ischemia (Bhat et a!., 1996) . The increased ex pression was observed 2 days after the transient ischemia and was localized to microglial cells. These data suggest the role of caspase-l in global ischemia is linked to the activation of a local inflammatory cascade, rather than being a trigger for apoptosis. The story of p53 and neuronal degeneration continues to evolve Chopp and Li 1996; Linnik 1996) .
This transcription factor sits at a crossroads between sur veillance of the genome for DNA damage, recruitment of the repair machinery, or alternatively tipping of the cell into an apoptotic cell death pathway as a final solution in maintenance of tissue integrity (Levine 1997). Several additional experiments with p53-knockout-mice showing a less severe outcome in neurons after kainic acid treat ment (Morrison et a!., 1996) or adrenalectomy (Sakhi et aI., 1996) add to those which have already shown attenu ation of ischemic damage Chopp and Li 1996; Linnik 1996) . Cultured neurons from such p53deficient animals have a decreased sensitivity to either glutamate excitotoxicity or genotoxins (Enokido et a!., 1996; Xiang et a!., 1996) . In addition, overexpression of p53 in either cultured cortical, hippocampal, or superior cervical ganglion neurons lead to apoptosis (Jordan et aI., 1996; Slack et a!., 1996; Xiang et aI., 1996) , while over expression of a dominant-negative truncated p53 pro tected neurons from spontaneous apoptotic death (Eizen berg et aI., 1996). Finally, increased expression of p53 has been reported after a cerebral ischemic insult (Chopp and Li, 1996 , Tomasevic et aI., 1996 although this is not always found (Nakagomi et aI., 1996) .
As a transcription factor, p53 upregulates several genes including bax and gadd45 (Smith and Fornace 1996; Levine 1997). Therefore it is of interest that, in this context, increases in bax have been reported to occur after cerebral ischemia in rats (Gillardon et aI., 1996b; , although in gerbils no increase in bax mRNA was seen (Honkaniemi et aI., 1996a) . Antisense oligonucleotides to bax prevented killing of cultured sympathetic neurons caused by neurotrophic deprivation (Gillardon et al. 1996c ). gadd45 is also increased after focal (Jin et aI., 1996) and global (Li et aI., 1997) isch emia. While the function of Gadd45 is not fully eluci dated, it has been shown to interact with PCNA which is a component of the DNA repair machinery (Kelman 1997; Smith and Fornace 1996) . The selective depletion of PCNA in ischemia-sensitive CAl cells of hippocam pus is therefore highly suggestive that some failure of the restoration machinery is involved with selective neuronal death in this brain area (Tomasevic et aI., 1996) .
OXIDATIVE STRESS
What might induce p53 expression? It is clear that the large burst of oxidants produced during an ischemic/ reperfusion episode play a major role in the ensuing ce rebral damage (Chan, 1996; Iadecola, 1997) . Such reac tive oxygen species are involved in neurotoxicity (Hosler and Brown, 1996) and can induce neuronal apoptosis (Bredesen 1996a,b; McConkey and Orrenius, 1996; Mattson and Furukawa, 1996) . The evidence for the im-1. P. MacMANUS AND M. D. LlNNIK portance of oxidative stress in ischemia comes from many directions including the use of pharmacological agents and antioxidants, and most compelling, from the use of transgenic and knockout animals for such genes as superoxide dismutase, catalase and nitric oxide synthase. A role for superoxide in producing ischemic neuronal death has been postulated in studies of transgenic mice overexpressing superoxide-dismutase (Chan 1996) but not in neuronal degeneration after kainate treatment (Ko ndo et aI., 1997). Because reactive oxygen species such as hydroxyl, superoxide, or nitric oxide radicals are so transient and technically difficult to measure, direct evi dence has been elusive. However, the report by P.K. contains direct measurements using a vari ety of analytical techniques and shows that after global cerebral ischemia, there was oxidative damage to the bases of DNA in the first hours of reperfusion, which although largely repaired, left some alterations which were also mutagenic. Because single strand breaks in neuronal DNA have also been described after ischemia (Tobita et aI., 1995) or excitotoxicity in vitra (Didier et aI., 1996) , there is plenty of opportunity for discontinu ities in the backbone of DNA to be a stimulant of the p53 surveillance system. A contrary report showing that, in stead of oxidation leading to subsequent p53 activation, p53 itself a Cf ts downstream to regulate the intracellular redox state in smooth muscle is most provocative and should be examined in brain (Johnson et aI. , 1996) .
Nitric oxide synthase
Besides hydroxyl and superoxide radicals, the nitric oxide (NO) radical is of great consequence in cerebral ischemia with its production increased at all stages sub sequent to ischemic injury (Dawson and Dawson 1996; ladecola, 1997; Szabo 1996) . Nitric oxide is an intri guingly small cellular messenger acting as a neurotrans mitter in both peripheral and central nervous systems, but also as a vasodilator. Nitric oxide is produced from L arginine by three separate isoforms of the calcium cal modulin-dependent enzyme NO synthase (NOS) termed nNOS in neurons, and eNOS in cerebral endothelial and hippocampal pyramidal cells. Normally the third iso form, iNOS (immunological) is not present in the CNS, but iNOS becomes a major source of NO after infiltra tion of neutrophils caused by brain injury. The most ap ropos review for our present purpose is that of ladecola (1997) which describes how the production of NO can be either beneficial (by eNOS) or detrimental (early by nNOS or later by iNOS). An increase in mRNA expres sion for both eNOS and nNOS occurs in the first hours after focal ischemia, to be followed up to 12 to 48 hours later by an increase in iNOS mRNA. The site of expres sion of the iNOS isoform can vary with whether the focal occlusion is transient or permanent: after transient occlu sion of the middle cerebral artery, iNOS is expressed J Cereb Blood Flow Metah, Vol. 17, No. 8, 1997 within 12 hours in endothelial cells, whereas after per manent occlusion iNOS is expressed after a delay of at least a day in infiltrating neurophils (Iadecola et aI., 1996; Zhang et aI. , 1996) . eNOS expression does in crease in cerebral blood vessels after traumatic brain in jury in which there is an ischemic component (Cobbs et a\. , 1997) . Many pharmacological agents have been used to elucidate the role of NO after ischemia (eg Zhang et aI. , 1996) , but the most striking exhibition of the detri mental action of NO has been shown by the attenuation of focal ischemic damage in mice with genetic knockout of either the nNOS or iNOS isoforms, but an opposite magnification of damage in mice with knockout of the eNOS isoform (ladecola 1997). A decrease in hippocam pal damage has also been shown in a global ischemia model in nNOS null mice (Panahian et aI., 1996) . The complexity of expression of NO coupled with the oppos ing actions of vasodilatory and excitotoxic actions make rational therapeutic targeting of NO non-trivial (ladecola 1997). Besides discussion of NO, the importance of com bination of NO with superoxide to form extremely nox ious peroxynitrite has been addressed (Dawson and Dawson 1996; Szabo 1996) . Peroxynitrite can cause DNA strand breaks, stimulate poly(ADP-ribosyl) poly merase and subsequently induce neuronal apoptosis. Us ing cultured cortical cells from nNOS null mice, it has been shown that NO-mediated neurotoxicity is primarily associated with activation of NMDA (and not kainate) receptors, and the provocative statement made that "NO may be responsible for as much as 80% of NMDA neu rotoxicity (Dawson et aI., 1996) .
Mitochondria and apoptosis
A heuristic body of work has emerged from attempts to build a cell-free system that would recapitulate the major nuclear events of cell death (Kraemer et aI., 1997).
Whether induced by oxidative stress or other stimuli, alterations in mitochondrial fu nction accompany apopto sis. There is a precipitous drop in mitochondrial mem brane potential that precedes formation of superoxide and DNA fragmentation (Kraemer et aI., 1997;  McCon key and Orren ius 1996). This transmembrane potential exists because of the assymetric distribution of protons on either side of the inner mitochondrial membrane re sulting in an electrical and protonic gradient that is es sential for mitochondrial function. The collapse of these gradients in apoptotic cells (including dying neurons) may be caused directly by opening of the permeability transition pore whose composition is unknown but which contains multimeric protein complexes. In building cell free systems to study cell death, it can be shown that cytoplasmic extracts of apoptotic cells can induce normal nuclei to show morphological characteristics and cleav age profiles of both protein and DNA indicative of ap optosis (X. Liu et aI., 1996) . In some of these cell-free systems, the cytoplasmic extracts have to be enriched with mitochondria (Zamzami et aI., 1996) . How failing mitochondria with open pores may directly induce apop tosis has possibly been revealed by the demonstration of release of proteins from mitochondria, for example cy tochrome C (X Liu et aI., 1996; Yang et aI., 1997) or a 50-kD apoptosis-inducing factor (Susin et aI., 1996) , both of which are involved in some way with the acti vation of caspases (Kluck et aI., 1997; Susin et aI., 1996; Yang et aI., 1997) . The mitochondrial factors responsible for induction of ' apoptotic nuclear changes are not en coded by mtDNA (Marchetti et aI., 1996) . The exact sequence of events may be different for the different inducers. In the Xenopus egg or mammalian cell models the release of cytochrome C precedes any collapse of mitochondrial gradients or permeability transition (Yang et aI., 1997; Kluck et a!., 1997) , whereas in mammalian cells a mitochondrial pore opening comes before the re lease of the 50 kD apoptogenic protein (Susin et aI., 1996; Zamzami et aI., 1996) . A critical sensor of the redox state of cells which links oxidative stress to mito chondria to apoptogenic protein release may reside in mitochondrial thiol groups (Marchetti et a!., 1997) .
Mitochondrial deenergization occurs in cultured neu rons induced to die by glutamate (Ankarcrona et a!., 1996a) , and has long been known to be associated with neuronal cell deafh after episodes of cerebral ischemia (Kristian and Siesjo 1996; Sies,jo and Siesjo 1996) . This deenergization is associated with collapse of the mito chondrial membrane potential and is accompanied by a permeability transition and the disruption of calcium ho meostasis. Cyclosporin A has the capacity to prevent the permeability transition (Kroemer et aI., 1997), and it is therefore of significance to our discussion that this im munosuppressor can significantly reduce ischemic dam age (Siesjo and Siesjo 1996) and block glutamate toxicity in vitro (Ankarcrona et aI., 1996a) . Also of significance is that the antiapoptotic gene Bcl-2 can prevent the mi tochondrial release of both the 50 kD apoptogenic pro tein (Susin et aI., 1996) and of cytochrome C (Yang et aI., 1997; Kluck et aI., 1997) . The continued application of these ideas in the arena of neuronal cells is greatly anticipated.
DNA FRAGMENTATION IN ISCHEMIC BRAIN
Because oligonucleosomal DNA fragmentation is a major hallmark of apoptosis (Bredesen 1996b; Hale et aI., 1996; Vaux and Strasser, 1996) , it is no wonder that it has been widely applied in investigations to ascertain a role for apoptosis in neuronal death. There have been innumerable reports showing electrophoretic patterns of laddered DNA fragments from either ischemic brain or other neurodegenerative situations (Charriaut-Merlan gue et aI., 1996a; Chopp and Li, 1996; Mehmet and Edwards, 1996) . Besides these 200 to 1000 bp low molecular weight DNA fragments, higher order fragments of 10, 50, or 300 to 700 kbp have also been detected after focal (Charriault-Merlangue et aI., 1996a) or global (MacManus et aI., 1997) ischemic insults, and also following glutamate toxicity in cultured cerebellar granule cells (Ankarcrona et aI., 1996b) .
The use of in situ end-labelling (TUNEL with terminal transferase or ISEL with polymerase) to detect DNA fragmentation in brain slices has also been extensive. Separately or in combination, these two techniques con tinue to be used in studies after either transient global Sakhi et a!., 1996) . The comparison of permanent with transient middle cerebral artery occlusion in mice indicated that less in situ end-labelling occurred in the absence of reperfusion (Murakami et aI., 1997) . A failure to show DNA fragmentation by these methods has been noted in prolonged somal survival of septohippocampal neurons after fornix-fimbria transection (Butterworth and Dragu now, 1996) , but the presence of TUNEL-positive cells without the convergent demonstration of electrophoretic demonstrable DNA fragmentation after kainic acid in duced seizures has been reported (Weiss et aI., 1996) .
Apoptotic endonucIeases
Most of the studies cited above that show oligonucleo somal DNA fragmentation after cerebral ischemia go no further with the analysis. It is concluded that the frag mentation is apoptotic. However, it may not be so simple. In a study that examined the end-groups pro duced in high molecular weight (10 to 50 kbp) DNA fragments in ischemic brain it was shown that, besides the production of 3'-OH end-groups which are docu mented in apoptosis, 5'-OH end-groups were also detect able (MacManus et aI., 1997). It was argued that at least two endonucleases would be needed to produce such fragmentation, and perhaps a third endonuclease to com plete cleavage to the widely demonstrated oligonucleo somal fragmentation. What is the nature of the endo nuclease producing DNA fragmentation in ischemic brain? This remains unknown because there are no pub lished reports on specific brain enzymes, but there are many candidates. Besides several endonucleases such as DNAse 1 and II and Nuc18 which have been implicated in apoptosis in non-neuronal cells (Bortner et aI. , 1995;  Wa lker et aI. , 1995), additional potential endonucleases have been described in apoptotic hepatoma (Pandey et aI., 1997) , lymphocytes (Collins et aI. , 1996; Khodarev and Ashwell, 1996) , and human leukemic cells (Fraser et aI., 1996) . It remains to be seen if any of these have a role to play in ischemic neuronal DNA fragmentation. The report of Collins et a1. (1996) is of particular interest because tQe newly described endonuclease produces DNA cleavage with 5'-OH end-groups in a DNAse II manner, although with a molecular weight at 45 kD it cannot be DNAse II (33 kD). Another issue relevant to ischemic cell death is the acidification during apoptotic cell death (McConkey and Orren ius 1996) which may activate acidic endonucleases such as DNAse II (Bortner et aI. , 1995; Walker et aI. , 1995) . In addition to DNAse, II several other acidic endonucleases have recently been described (Collins et aI., 1996; Gottlieb et aI., 1996; Os tad et aI., 1996) . The early intracellular acidification be fore detectable DNA fragmentation has been docu mented by flow cytometry by Gottlieb et a1 . (1996) . Also of interest is that the simple lowering of the pH in the culture medium of HL60 cells from pH 7.6 to pH 6.8 was sufficient to induce apoptotic DNA fragmentation (Park et aI. , 1996) , and the intriguing idea was raised that on cogene bl�ckage of apoptosis may be because of a pre vention of acidification (Ostad et aI., 1996) . Because of the long-established acidification of the ischemic brain caused by lactate accumulation, all of the work on cel lular acidification and activation of acid endonuclease in standard cancer cell lines needs to be revisited in a neu ronal context.
The hunt for the elusive endonuclease responsible for apoptotic oligonucleosomal DNA fragmentation has not bagged any prize enzyme, which is irrefutably the one which gives the observed electroporetic patterns. An al ternate, and sobering, idea is that this hunt is futile. Pro vocative experiments suggest that the cleavage of DNA may not be enzymatic, but produced instead by chemical nuclease action, most likely by hydroxyl radical. A sys tem of hydroxyl radical generation using copper phen anthroline complexes were shown to be capable of gen erating laddered DNA fragments in isolated liver nuclei (Burkitt et a1. 1996) and also in cultured liver cells (Tsang et a1. 1996) . Similar findings with isolated chro matin (presumably lacking any contaminating endo nuclease) suggest some preferential modification of in ternucleosomal regions perhaps by the insertion of 8-oxoG lesions in the DNA backbone (Enright et al. 1996; Tsang et a1 . 1996) which would lead to subsequent strand scission. This somewhat heretical suggestion of chemical nuclease action by hydroxyl radical cannot be overlooked in the area of cerebral ischemia because of the evidence, alluded to above, of oxidative damage to J Cereh Blood Flow Metab. Vol. 17. No. 8, 1997 DNA after global ischemia (Chan 1996; PK Liu et a1. 1996) . In this regard, the family of repair endonucleases (apurinic endonucleases) involved with base-excision re pair of DNA and which are capable of recognizing some of the oxidative base lesions described in ischemic brain (PK Liu et aI., 1996) may become involved. These repair endonucleases are expressed in brain (Wilson et aI., 1996) , but the single report concerning ischemia indi cates a reduction of this enzyme in CAl hippocampal cells before DNA fragmentation (Walton et aI., 1996a) . Because the majority of DNA damage produced after an ischemic insult is rapidly repaired (P. K. Liu et aI., 1996) , other repair endonucleolytic activities such as those in volved with nucleotide-excision repair must be respon sible. Another cellular entity responding to radical in duced DNA damage is poly(ADP-ribosyl) polymerase (Szabo 1996) , and the possibility should be considered that the increased susceptibility of chromatin to cellular endonuclease may also be achieved by poly(ADP ribosyl)ation of histone HI, which resides in the inter nucleosomal linker region (Yoon et aI., 1996) .
APOPTOTIC MORPHOLOGY AFTER
CEREBRAL ISCHEMIA: A VEXATIOUS ISSUE
Distinguishing apoptosis from necrosis can be a con tentious task . Apoptosis was first delineated from necrosis in 1972 on morphological grounds using electron microscopy. In neurons, as in other cells, the principal observable feature in the light microscope is nuclear "aggregation of chromatin into dense sharply delineated masses" (Charriault-Marlangue et aI. , 1996a). There also has been wide use of in situ end labelling to detect DNA fragmentation (see above) which unfortunately alone cannot discriminate between apop tosis and necrosis although occasionally claims to the contrary are made based on intensity and location of label (Charriault-Marlangue et aI. , 1996a). Although some scepticism exists (Yanker 1996) , this lack of dis crimination is not appreciated by many and has lead to the deplorable use of TUNEL as a facile yardstick for the presence of apoptotic neurons in a whole host of diseases such as Alzheimer's and Parkinson's. It is to be hoped that further work will prove these hasty conclusions to be correct.
Neurons dying by programmed cell death during de velopment do show morphological (and biochemical) hallmarks of apoptosis (Portera-Calli au et aI., 1997 a; Ross 1996). In neonatal models of hypoxia/ischemia, the dying neurons show chromatin coalescence (karyor rhexis) and laddered DNA fragmentation (Edwards and Mehmet 1996; Ferrer 1996) , and have an neonatal age dependent exhibition of apoptotic morphology in re sponse to excitotoxicity (Kelly and Burke, 1996; Portera Calliau et aI., 1997a) . However, in adult models of isch-emia, the morphological evidence to date is not consistent to say the least (Charriault-Marlangue et aI., 1996a; Kirino 1996) . Coalescence of chromatin has been recorded after focal ischemia particularly in the penum bral area on the edge of the infarct (Charriault Marlangue et aI., 1996b; Chopp and Li 1996; States et aI., 1996) , but this was not confirmed in a rigorous ul trastructural study (van Lookeren Campagne and Gill, 1996) . Also to be considered, albeit only with light mi croscopic resol�tion, is the lack of coalesced or margin ated nuclear morphology in TUNEL or ISEL end-labeled nuclei in myriad previous reports on adult ischemic ani mals, and including those recently appearing (Du et aI., 1996; Gillardon et aI., 1996a,b; Jin et aI., 1996; Schmidt Kastner et aI., 1997) . It is always appropriate in times of doubt to revisit the old masters. A quote from one of the founding fathers of the field of apoptosis should give pause: "T he need for ultrastructural confirmation of light microscopic identification of dying cells will be evident. Despite the difference between the processes of apoptosis and necrosis, the terms pyknosis and karyor rhexis can be legitimately used to describe the appear ances in the light microscope of certain phases in the evolution of both" (Wyllie et aI., 1980) .
Not apoptosis nor necrosis
Instead of tryrng to apply black and white definitions of apoptosis versus necrosis to ischemic cell death based on the inadequate light microscopy evidence, a more useful postulate may be that neuronal cell death after ischemia should be considered in its own right without name calling. Maybe those using other models of neu ronal degeneration have already pointed the way in showing that, for example, cortical impact injury elicits hippocampal damage (Colicos and Dash 1996) 1996) . The intense research activity in this area has cooled in recent years but several reports con tinue to argue the relevance of increases in lEG mRNA after global and focal ischemia in the adult (Gillardon et aI., 1996b; Lin et aI., 1997; Nakagomi et aI., 1996; Wiessner et aI., 1996) and neonate (Ferrer 1996) , or after experimental brain injury (Raghupathi and Mcintosh 1996) . Another family of lEG are the zinc-finger family, which include NGFI-A, B and C, egr-2 and 3, and Nurrl , and have been shown to change after global ischemia (A kins et aI., 1996; Honkaniemi and Sharp 1996b) . All of these transcription factors (except egr-2 and Nurrl) were induced in brain areas, especially hippocampus, which are known to be susceptible to ischemic damage. Persis tent expression of these lEG did not correlate with whether cells are destined to die because NGFI-C and egr-3 were present in dentate granule neurons for a pro longed period. It was suggested that the combination of transcriptional activation with lack of negative feedback because of blocked translation might explain the general prolonged expression of these lEG in particular, but also perhaps in general to include Fos and Jun (Honkaniemi and Sharp 1 996b).
Immediate early genes and repair
Despite the above apparently irrefutable evidence for a role in cell death for the lEG, an disconcerting alternate view suggests that jos and jun may be components of an J. P. MacMANUS AND M. D. UNNIK adaptive or repair/regeneration process because many cells that have increased expression actually survive in sults such as excitotoxicity (Akins et aI ., 1996; Herzog and Morgan 1996; Hughes and Dragunow 1995). Such a radical idea also comes from the surprising finding of normal cell death in fo s-null mice, and the lack of effect on neuronal cell death in the spinal chord after sciatic nerve resection in such knockout animals (Roffler Tarlov et aI., 1996) . The clever use of fasting as a chal lenge to such a nuturing role for c-fo s yielded corrobo ration in the demonstration of prolonged and enhanced expression after focal ischemia in hypoglycemic animals which are well known to have less damage fo llowing an ischemic insult (Lin et aI., 1997). Further support comes from studies showing increasedjos or junD mRNA in the resistant hippocampal dentate area using a chest com pression model of global cerebral ischemia (Tseng et aI., 1997) , or after transient global ischemia with postisch emic hypothermia (Kamme and Wieloch 1996) , respec tively. A third view would be that the lEG are involved in both cell death and adaptive/stress response, and it is the cellular context that is important, eg hippocampal CAl pyramidal or dentate granule cells. It is this context that is not understood (McConkey and Orrenius 1996).
The statement made at the beginning of this article could be rewritttm to " signals that promote apoptosis in one cell type can suppress cell death in another" .
Heat shock proteins
Another aspect of an adaptiveiregeneration response in the brain to ischemic insults concerns heat shock pro teins whose expression is increased in both neurons and glial cells (A kins et aI., 1996; Kirino 1996; Massa et aI., 1996) . Global ischemia induced hsp70 expression throughout the hippocampal area before any degenera tion of the CAl layer (Wiessner et aI., 1996) , and after focal ischemia, cells that had increased expression of hsp70 did not show DNA fragmentation by in situ end labelling (States et ai., 1996) . From such studies arise ideas that the hsp70-stained cells are reversibly injured and likely survive the ischemic insult, perhaps in a way analogous to the cells identified above as gadd45 posi tive (Jin et aI., 1996) , or c-fo s positive (Lin et ai., 1997).
Because an ischemic insult does engender a stress re sponse, it should not be a surprise that accumulating evidence indicates that brief, not obviously harmful, epi sodes of ischemia in either brain or heart induce toler ance to a second ischemic insult (Chen and Simon 1997; Massa et ai., 1996) . In either case of induced tolerance, increased cerebral gene expression would seem to be involved, and attractive candidates would be rEG, heat shock proteins such as hsp70, or antiapoptotic gene fami lies such as the Bcl-2 family or the lAP family (Liston et aI., 1996) The preceeding text has been governed by the demo graphics of the extant literature on gene expression, pri marily in neurons, after an ischemic insult to the brain. However, research in other areas must not be ignored. There have been individual reports of interest which may blossom in the future to the monumental impact of the lEG, bcl2 or caspases, and extend studies beyond the neurocentrism of the moment.
Myc
Besides fo s, jun and p53, cancer research has also led to the recognition of the importance of another transcrip tion factor, c-Myc, in regulating apoptosis (Henriksson and Luscher 1996; Zorning and Evan 1996). The nuclear phosphoprotein c-Myc is involved in cell cycle regula tion and is not generally expressed in nonproliferating or quiescent cells. Few genes have actually been identified as targets for c-Myc transactivation, but one is p53.
Overexpression of c-myc primes cells for apoptosis and facilitates the adverse effects of lack of nutrients or oxy gen (Alarcon et aI. 1996; Graeber et aI., 1996) . Such conditions exist in the ischemic brain and it is therefore of interest that an up-regulation of c-myc expression has been reported after focal occlusion (Nakagomi et aI., 1996) . Another target gene of c-Myc is ornithine decar boxylase (Henriksson and Luscher 1996) which has been seen to increase after cerebral ischemia, although its overexpression in transgenic rats was unsuccessful in influencing infarct volume (Lukkarinen et aI., 1997) .
Neuronal apoptosis inhibitory protein
Besides Bcl2, there is a another family of proteins known to inhibit apoptosis: the inhibitors of apoptosis family, which was first identified in viruses such as bacu lovirus or cowpox virus that impede apoptosis to prolong the life of infected host cells (Bredesen 1996b; Vaux and Strasser 1996). The mammalian homologues have now been identified and shown to inhibit apoptosis in mam malian models (Duckett et aI., 1996; Liston et aI., 1996; Uren et aI., 1996) . One of these homologues is the gene for spinal muscular atrophy (neuronal apoptosis inhibi tory protein) which is widely expressed in the brain, but in particularly high levels in exactly those neuronal populations that are known to degenerate in diseased children (Xu et aI., 1997) . Studies on the expression of these antiapoptotic genes in other neuron ally injurious situations including cerebral ischemia is keenly awaited.
Hypoxia-regulated genes
The expression of a novel oxygen regulated stress pro tein ORP150 was described in ischemic mouse brain (Kuwabara et aI., 1996) , and may be the first signs of a research thrust in the area concerning genes of the brain that are regulated by hypoxia. Cancer research is again heuristic in demonstrating that tissues have a plethora of responses available when confronted with hypoxia, in cluding upregulation of many transcription factors such as fos, jun, and p53, in addition to stress proteins such as hsp70. Another helix-loop-helix transcription factor first described in 1993, hypoxia-inducible factor, has been show n to influence the expression of many oxygen regulated genes . (Dachs and Stratfo rd, 1996) . The recog nized target repertoire of hypoxia-inducible factor-1 now includes genes such as erythropoietin, vascular endothe lial growth factor, aldolase, enolase, lactate dehydroge nase, and heme oxygenase-l (Lee et a!., 1997; Semenza et aI. , 1996) . Hypoxia-inducible factor-l is present in brain, and its expression increases after exposure of ani mals to hypoxia (Wiener et a!. , 1996) . Therefore, in creased gene expression for heme-oxygenase after either global or focal ischemia may come as no surprise (Massa et a!., 1996; Geddes et a!. , 1996; Takeda et a!. , 1996) . It is easily predicted that this arena will become more crow ded in the coming few years as the potential for exploiting new knowledge in oxygen-controlled gene ex pression in the brain is realized.
Transcription regulation
Many of the � troke-induced changes in gene expres sion result from changes in the relative distribution of the transcription factors that transactivate these genes. Some changes in transcription factor expression can be directly linked to cell death, such as the induction of the tran scription factor p53 transactivating the proapoptotic pro tein Bax (Smith and Fornace, 1996; Levine, 1997). How ever, interpreting the consequences of changes in the expression of transcription factors requires careful analy sis because these factors are highly context dependent. A good example of this context dependency is NF-KB, a transcription factor that is sequestered in the cytoplasm by the inhibitory protein IKB (Lipton, 1997; Baichwal and Baeuerle, 1997) . When IKB is phosphorylated and/ or cleaved, NF-KB is free to translocate to the nucleus where it influences the expression of a wide variety of genes, including many stress activated genes. The levels of NF-KB are elevated in several degenerative diseases, including stroke (Terai et a!. , 1996a) and Alzheimer' s disease (Kaltschmidt et a!., 1997; Terai et a!., 1996b; Barger and Mattson 1996) and Grilli et a!. (1996) showed that blocking NF-KB activation by aspirin or sodium sa licylate could protect neurons against an excitotoxic in sult. While these data suggest that NF-KB activation is detrimental, several studies have shown that NF-KB ac tivation blocks apoptosis to a variety of insults (Beg and Baltimore, 1996; Van Antwerp et a!. , 1996; ZG Liu et a!., 1996) and can be neuroprotective (Goodman and Mattson 1996) . Thus, this well under-stood transcription factor can be both protective and det rimental, depending on the context in which it is ex pressed and the nature of the insult. Transcriptional regu lation remain relatively unexplored in the context of ischemic neuronal death, and these types of studies will be necessary to fully understand the basis for chancres in 1:0 gene expression that are induced by cerebral ischemia.
Minorities
There are scattered reports of increases in neurotroph ins and various excitatory amino acid receptors follow ing an ischemic insult which have been reviewed by Akins et a!. (1996) . The link between cell proliferation and apoptosis has been touched on by many (Desbarats et a!. , 1996; McConkey and Orren ius (1996) and ex tended to neurgenesis and neuronal apoptosis as well . After kainic acid treatment, an increase of the cell-cycle protein cyclin D1 was reported in astro cytes (W Liu et a!., 1996) . Ischemia-induced increases in gene expression in astrocytes were described for I)-amy loid precursor proteins (Kositinaho et a!., 1996) , clusterin (Walton et a!., 1996b) , and the neurofibromatosis gene product NF l (Giordano et a!. , 1996) . What function these may have is unclear, but these upregulated gene products may be involved in the response to injury and the initia tion of cellular remodelling. There have been singularly few studies on ischemic human brain but a notable ex ception showed increases in TGF-l) l in all cell types, particularly in the penumbral zone (Krupinski et a!., 1996) .
CONCLUSION
It is hoped that the basic science in animal models will be applicable to the human condition of stroke. Encour agement for continuation with investigation in funda mental mechanisms of cell death come from the finding of substantial amounts of potentially viable brain tissue in stroke patients (Marchal et a!. , 1996) .
The early work on lEG after ischemia was inspira tional and indubitably encouraged further work on ex pression of other genes as discussed in this article. The realization that, despite a decade of work by a host of investigators producing a mountain of publications, the last word on lEG in cell death is a long way from being written is a sobering thought. Much patience and dedi cated research lie ahead before as much wisdom as has been acquired from lEG research will be available for the host of other genes under investigation after an ischemic insult. The basic preclinical research on this subject con tinues apace (Karpati et aI., 1996) with the hope of de fining practical concepts that can be implemented in the clinic.
